Quinazoline derivatives as medicaments
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 5, 2002
Issued Date -
N/A
app pub date -
Aug 27, 1999
filing date -
Aug 28, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention is directed to methods to inhibit TGF-.beta. and/or p38-.alpha. kinase using compounds of the formula ##STR1## or the pharmaceutically acceptable salts thereof wherein R.sup.3 is a noninterfering substituent; each Z is CR.sup.2 or N, wherein no more than two Z positions in ring A are N, and wherein two adjacent Z positions in ring A cannot be N; each R.sup.2 is independently a noninterfering substituent; L is a linker; n is 0 or 1; and Ar' is the residue of a cyclic aliphatic, cyclic heteroaliphatic, aromatic or heteroaromatic moiety optionally substituted with 1-3 noninterfering substituents.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully